A murid gamma-herpesviruses exploits normal splenic immune communication routes for systemic spread

Bruno Frederico1, Brittany Chao1, Janet S May1

  • 1Division of Virology, Department of Pathology, University of Cambridge, Cambridge CB2 2QQ, UK.

Cell Host & Microbe
|April 12, 2014
PubMed

Insights

Murid herpesvirus-4 (MuHV-4) exploits spleen immune cells like macrophages and B cells to establish chronic infection. Blocking these pathways protects mice, revealing a novel viral spread mechanism.

Area of Science:

  • Virology
  • Immunology
  • Pathogen Biology

Background:

  • Gamma-herpesviruses (γHVs) are oncogenic pathogens infecting lymphocytes.
  • Mechanisms of spleen immune evasion by γHVs for persistent infection remain unclear.

Purpose of the Study:

  • To elucidate how Murid herpesvirus-4 (MuHV-4) utilizes spleen architecture to establish persistent infection.
  • To identify key cellular targets and pathways exploited by MuHV-4 in the spleen.

Main Methods:

  • Tracking MuHV-4 infection in mouse spleens using cellular and molecular techniques.
  • Utilizing knockout mice lacking specific immune cell populations (MZ B cells).
  • Employing pharmacological agents (sphingosine-1-phosphate receptor agonist) to disrupt immune cell localization.

Main Results:

  • MuHV-4 infects marginal zone (MZ) macrophages, facilitating transfer to MZ B cells.
  • Virus spreads from MZ B cells to follicular dendritic cells and then to germinal center B cells for persistence.
  • Mice lacking MZ B cells or treated to dislocate them showed protection against MuHV-4 colonization.
  • MuHV-4 mutants lacking ORF27 exhibited impaired long-term infection despite initial macrophage entry.

Conclusions:

  • MuHV-4 employs a serial lymphoid/myeloid exchange strategy, exploiting normal immune communication routes within the spleen.
  • Targeting MZ macrophages and MZ B cells offers a potential therapeutic strategy against MuHV-4 infection.
  • Understanding this viral dissemination pathway is crucial for controlling γHV persistence and oncogenesis.